Analyze Diet

Eosinophilic keratoconjunctivitis in seven horses.

Abstract: Eosinophilic keratoconjunctivitis was diagnosed in 7 horses at The Ohio State University between 1976 and 1994. All horses had moderate-to-severe blepharospasm, chemosis, and conjunctival hyperemia; epiphora; and extensive yellow-to-white caseous mucoid discharge. Corneal ulcers associated with this disease were perilimbal and extended centrally. All ulcers were covered with a white necrotic plaque firmly attached to the underlying cornea. Other ophthalmic abnormalities were not detected. Corneal scrapings examined cytologically contained numerous eosinophils interspersed between epithelial cells, few mast cells, and neutrophils. Microbial organism were not seen. Bacterial and fungal cultures were negative for ocular pathogens. The initial diagnosis of eosinophilic keratoconjunctivitis was made on the basis of clinical and cytologic findings. In 5 horses, the condition completely resolved after topical treatment with corticosteroid (0.05% dexamethasone) and triple antibiotic ointments. However, the duration of treatment was prolonged, with a mean treatment time of 64 days (range, 45 to 106 days). All corneal ulcers remained superficial, and despite the prolonged duration of treatment, none of the horses developed secondary bacterial or fungal keratitis. One horse underwent superficial keratectomy and had the shortest resolution time (14 days).
Publication Date: 1996-10-01 PubMed ID: 8837652
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on seven cases of eosinophilic keratoconjunctivitis in horses examined at The Ohio State University between 1976 and 1994, investigating the symptoms, findings, and treatment methods used and their outcomes.

Background

  • This study centers on eosinophilic keratoconjunctivitis, a specific type of eye inflammation in horses.
  • The researchers examined seven reported cases at The Ohio State University over an eighteen-year period, from 1976 to 1994.

Findings

  • All seven horses diagnosed with eosinophilic keratoconjunctivitis exhibited moderate-to-severe signs of eye discomfort and inflammation. These signs included blepharospasm, chemosis, and conjunctival hyperemia, all terms that refer to eye muscle contractions, swelling, and abnormal blood vessel dilation, respectively.
  • The horses also produced an excessive amount of yellow-to-white, cheese-like eye discharge, stemming from corneal ulcers related to the disease. These ulcers were present in a perilimbal pattern, meaning they occurred along the circular border between the white and colored parts of the horse’s eye, and extended centrally.
  • Corneal scrapings examined under a microscope revealed the presence of numerous eosinophils, a type of white blood cell, interspersed with epithelial cells, few mast cells (another type of white blood cell), and neutrophils (a subtype of white blood cell responsible for fighting off bacteria and fungi).
  • No microbial organisms were identified in these corneal scrapings, and bacterial and fungal cultures showed negative results for pathogenic organisms.

Treatment and Outcomes

  • Eosinophilic keratoconjunctivitis was conclusively diagnosed based on clinical signs and cytological findings. Five of the affected horses completely recovered after local treatment with corticosteroid and triple antibiotic ointments.
  • The mean treatment time spanned 64 days, ranging from a 45 to 106-day period.
  • Despite this extensive treatment period, the corneal ulcers caused by the disease remained superficial, meaning they did not penetrate the thinner, front part of the horse’s cornea. Additionally, no secondary bacterial or fungal keratitis (corneal infections) developed during this period.
  • One horse underwent a superficial keratectomy, a surgical removal of the cornea’s outer layer, and experienced the quickest recovery time at only 14 days post-procedure.

Cite This Article

APA
Yamagata M, Wilkie DA, Gilger BC. (1996). Eosinophilic keratoconjunctivitis in seven horses. J Am Vet Med Assoc, 209(7), 1283-1286.

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 209
Issue: 7
Pages: 1283-1286

Researcher Affiliations

Yamagata, M
  • Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Ohio State University, Columbus 43210, USA.
Wilkie, D A
    Gilger, B C

      MeSH Terms

      • Administration, Topical
      • Animals
      • Anti-Bacterial Agents / administration & dosage
      • Anti-Bacterial Agents / therapeutic use
      • Anti-Inflammatory Agents / administration & dosage
      • Anti-Inflammatory Agents / therapeutic use
      • Conjunctiva / pathology
      • Cornea / pathology
      • Cornea / surgery
      • Dexamethasone / administration & dosage
      • Dexamethasone / therapeutic use
      • Drug Combinations
      • Eosinophilia / drug therapy
      • Eosinophilia / pathology
      • Eosinophilia / veterinary
      • Female
      • Glucocorticoids
      • Horse Diseases / drug therapy
      • Horse Diseases / pathology
      • Horses
      • Keratoconjunctivitis / drug therapy
      • Keratoconjunctivitis / pathology
      • Keratoconjunctivitis / veterinary
      • Male
      • Ointments

      Citations

      This article has been cited 2 times.
      1. Knickelbein KE, Luethy D, Thomasy SM, Reilly C, Strom AR, Lassaline ME. Equine eosinophilic keratoconjunctivitis in California: retrospective study of 47 eyes from 29 cases (1993-2017). Vet Ophthalmol 2019 Jul;22(4):510-519.
        doi: 10.1111/vop.12621pubmed: 30706617google scholar: lookup
      2. Edwards S, Clode AB, Gilger BC. Equine eosinophilic keratitis in horses: 28 cases (2003-2013). Clin Case Rep 2015 Dec;3(12):1000-6.
        doi: 10.1002/ccr3.350pubmed: 26734136google scholar: lookup